Sleep Intervention for Oppositional Defiant Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist children with Oppositional Defiant Disorder (ODD) who experience insomnia. It tests a telehealth cognitive behavioral treatment for insomnia (CBT-I) called SLEEP: COPE, which includes techniques like sleep hygiene and behavioral strategies involving both the child and their parents. The trial targets children aged 8-12 diagnosed with ODD who have ongoing sleep issues, such as difficulty falling or staying asleep, impacting their daily life for over three months. Telehealth delivery facilitates participation for families in areas with limited mental healthcare access. As an unphased trial, this study provides families the opportunity to access innovative treatment strategies that could enhance their child's sleep and overall well-being.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, children on psychotropic or other medications that alter sleep, except for stimulants, sleep medications, and melatonin, are excluded from participating.
Will I have to stop taking my current medications?
The trial does not require children to stop taking their current medications, except for those that alter sleep, unless they are stimulants, sleep medications, or melatonin.
What prior data suggests that this telehealth CBT-I method is safe for children with ODD?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) is a safe and effective treatment for insomnia in both adults and children. This includes the online version used in the SLEEP: COPE program. The therapy employs techniques such as sleep hygiene (practicing good sleep habits) and sleep restriction (spending less time in bed to improve sleep quality), which have been well-received by other groups.
Although SLEEP: COPE has not been specifically tested in children with Oppositional Defiant Disorder (ODD), the main CBT-I methods have a strong safety record in similar situations. Studies have not identified any serious side effects from these techniques in other groups. This suggests that the treatment is likely safe for children with ODD, although specific testing for this group continues.12345Why are researchers excited about this trial?
Unlike the standard care for Oppositional Defiant Disorder (ODD), which often involves behavioral therapy and medication, SLEEP: COPE is unique because it integrates cognitive behavioral therapy for insomnia (CBT-I) specifically tailored for children with ODD and their parents. It combines traditional sleep hygiene practices with techniques designed to engage both children and parents, focusing on collaborative behavioral strategies. Researchers are excited about this approach because it addresses sleep issues, which are common in children with ODD, potentially improving both sleep and behavioral symptoms simultaneously.
What evidence suggests that SLEEP-COPE might be an effective treatment for Oppositional Defiant Disorder?
Studies have shown that cognitive behavioral therapy for insomnia (CBT-I) greatly improves sleep and reduces insomnia symptoms in teenagers. Research also shows that delivering CBT-I through telehealth works well for both adults and children, making it a good option for those who can't easily attend in-person sessions. This trial will evaluate the SLEEP: COPE program, which incorporates CBT-I techniques specifically for children with Oppositional Defiant Disorder (ODD). Early findings suggest that CBT-I can help with insomnia and related issues like mood problems and rule-breaking, which are common in children with ODD. Telehealth CBT-I is especially helpful for reaching children with ODD because it can involve parents in using behavioral strategies, enhancing the treatment's effectiveness.12367
Are You a Good Fit for This Trial?
This trial is for children aged 8-12 with Oppositional Defiant Disorder (ODD) and chronic insomnia. They must have had sleep difficulties for over three months, affecting their mood or daily functioning. Both child and parent need to speak English. Children who don't meet the specific sleep problem criteria or have other conditions that could interfere are not eligible.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive telehealth CBT-I sessions targeting sleep and behavioral issues in children with ODD
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SLEEP: COPE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor